Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simonetta Galgani

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Multiple Sclerosis and Related Disorders|December 7, 2016
Extratemporal herpes encephalitis during natalizumab treatment: A case reportShalom Haggiag, Luca Prosperini, Simonetta Galgani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 26, 2020
Age-related adverse events of disease-modifying treatments for multiple sclerosis: A meta-regressionLuca Prosperini, Shalom Haggiag, Carla Tortorella, et al.
Emerging Infectious Diseases|September 13, 2016
Zika Virus Infection in the Central Nervous System and Female Genital TractEmanuele Nicastri, Concetta Castilletti, Pietro Balestra, et al.
Journal of Neurology|July 19, 2018
Early transient asymptomatic neutropenia associated with alemtuzumab treatment in multiple sclerosis: a case reportSimonetta Galgani, Luca Prosperini, Shalom Haggiag, et al.
Journal of Neurology|January 5, 2022
Determinants of COVID-19-related lethality in multiple sclerosis: a meta-regression of observational studiesLuca Prosperini, Carla Tortorella, Shalom Haggiag, et al.
Journal of Neurology|September 17, 2021
Increased risk of death from COVID-19 in multiple sclerosis: a pooled analysis of observational studiesLuca Prosperini, Carla Tortorella, Shalom Haggiag, et al.
Expert Opinion on Pharmacotherapy|February 18, 2011
Painful and involuntary multiple sclerosisFrancesca Bagnato, Diego Centonze, Simonetta Galgani, et al.
Brain Sciences|October 25, 2024
Estimating the Prevalence of Cognitive Impairment and Its Associated Factors in Albania: A Nationwide Cross-Sectional StudyMalvina Hoxha, Simonetta Galgani, Jera Kruja, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 11, 2011
Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosisLuca Prosperini, Costanza Giannì, Laura Leonardi, et al.
BMC Infectious Diseases|March 19, 2013
Varicella zoster virus infection presenting as isolated diplopia: a case reportRaffaella Pisapia, Alessia Rianda, Andrea Mariano, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Multiple Sclerosis and Related Disorders|December 7, 2016
Extratemporal herpes encephalitis during natalizumab treatment: A case reportShalom Haggiag, Luca Prosperini, Simonetta Galgani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 26, 2020
Age-related adverse events of disease-modifying treatments for multiple sclerosis: A meta-regressionLuca Prosperini, Shalom Haggiag, Carla Tortorella, et al.
Emerging Infectious Diseases|September 13, 2016
Zika Virus Infection in the Central Nervous System and Female Genital TractEmanuele Nicastri, Concetta Castilletti, Pietro Balestra, et al.
Journal of Neurology|July 19, 2018
Early transient asymptomatic neutropenia associated with alemtuzumab treatment in multiple sclerosis: a case reportSimonetta Galgani, Luca Prosperini, Shalom Haggiag, et al.
Journal of Neurology|January 5, 2022
Determinants of COVID-19-related lethality in multiple sclerosis: a meta-regression of observational studiesLuca Prosperini, Carla Tortorella, Shalom Haggiag, et al.
Journal of Neurology|September 17, 2021
Increased risk of death from COVID-19 in multiple sclerosis: a pooled analysis of observational studiesLuca Prosperini, Carla Tortorella, Shalom Haggiag, et al.
Expert Opinion on Pharmacotherapy|February 18, 2011
Painful and involuntary multiple sclerosisFrancesca Bagnato, Diego Centonze, Simonetta Galgani, et al.
Brain Sciences|October 25, 2024
Estimating the Prevalence of Cognitive Impairment and Its Associated Factors in Albania: A Nationwide Cross-Sectional StudyMalvina Hoxha, Simonetta Galgani, Jera Kruja, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 11, 2011
Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosisLuca Prosperini, Costanza Giannì, Laura Leonardi, et al.
BMC Infectious Diseases|March 19, 2013
Varicella zoster virus infection presenting as isolated diplopia: a case reportRaffaella Pisapia, Alessia Rianda, Andrea Mariano, et al.
Pageof 4